Optimization of Small Molecule Probes for the Nervous System (STTR [R41])
The summary for the Optimization of Small Molecule Probes for the Nervous System (STTR [R41]) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Optimization of Small Molecule Probes for the Nervous System (STTR [R41]): Purpose This Funding Opportunity Announcement (FOA) encourages Small Business Technology Transfer (STTR) grant applications from small business concerns (SBCs) that propose to develop new small molecule probes for investigating biological function in the nervous system via the application of advanced medicinal chemistry and the biological testing of compounds. Eligible SBCs will have identified probe candidates via screening of small molecule collections, using in vitro assays of biological activity developed to interrogate these collections, and be able to show that the structural features of these small molecules are related to their biological activity. Applications should nominate small molecule probe candidates from distinct structural series for the further, iterative design and testing of analogues in structure-activity relationship studies, using in vitro assays of biological function adapted to the medium throughput screening requirements of this work. These studies should have the goal of developing a small molecule probe possessing the attributes (eg: affinity, selectivity, activity) required for its use in future pharmacological studies proposed by the SBC. Applicants are strongly encouraged to utilize publicly available cheminformatic capabilities for the acquisition of compounds, and semi-custom synthesis of analogues, which is required of these studies. Mechanism of Support. This FOA will utilize the STTR (R41) grant mechanism for Phase I, and runs in parallel with FOAs of identical scientific scope that encourage applications under the Small Business Innovation Research (SBIR) (R43) grant mechanism (PAR-09-260, and the R21 grant mechanism (PAR-09-251). Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received.
Federal Grant Title: | Optimization of Small Molecule Probes for the Nervous System (STTR [R41]) |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Education Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | PAR-09-259 |
Type of Funding: | Grant |
CFDA Numbers: | 93.273 |
CFDA Descriptions: | Alcohol Research Programs |
Current Application Deadline: | Sep 07, 2012 |
Original Application Deadline: | Sep 07, 2012 |
Posted Date: | Aug 26, 2009 |
Creation Date: | Aug 26, 2009 |
Archive Date: | Oct 08, 2012 |
Total Program Funding: | |
Maximum Federal Grant Award: | $150,000 |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Small businesses
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]] - Similar Government Grants
- • Limited Competition: Alcohol-associated Hepatitis Clinical Network Integrated Treatment C...
- • Limited Competition: Alcohol-associated Hepatitis Clinical Network Integrated Treatment C...
- • Model Continuums of Care Initiative (MCCI) to Advance Health Equity and End Health Dispari...
- • Limited Competition: Collaborative Study on the Genetics of Alcoholism (COGA) (U10 Clinica...
- • Pilot and Feasibility Studies in Preparation for Substance Use Prevention Trials (R34 Clin...
- • Mechanisms of Alcoholic Pancreatitis
- • Alcohol Abuse and Hiv/Aids in Resource-Poor Societies
- • Mechanisms of Alcohol-Induced Tissue Injury
- More Grants from the National Institutes of Health
- • The NCI Worta McCaskill-Stevens Career Development Award for Community Oncology and Preven...
- • Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional)
- • Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Tri...
- • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...
- • HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggabl...